Gross profit increased 17.2%
Gross profit changed +17.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross profit changed +17.2% from the comparable as-filed period.
Research & development changed +15.7% from the comparable as-filed period.
Cash & equivalents changed -6.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross margin changed -26 basis points from the comparable as-filed period.
Stock-based compensation changed +12.2% from the comparable as-filed period.
SBC / revenue changed -71 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.